Authored by Partha Kar, published on 2026-04-27 18:50:05.0
The algorithm is broadly aligned with contemporary hyperprolactinaemia care: confirm true elevation, exclude physiologic/secondary/drug causes (including macroprolactin), proceed to pituitary MRI when persistent, and treat symptomatic prolactinomas primarily with dopamine agonists (cabergoline preferred). It appropriately places transsphenoidal surgery as second-line for intolerance/resistance or urgent complications and includes reasonable follow-up and consideration of dopamine-agonist withdrawal after sustained remission. Overall, it reflects major Endocrine Society/Pituitary Society recommendations, though some thresholds and follow-up intervals may vary by guideline and local practice.